Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Journal of General Internal Medicine
|
October 20, 2009
Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy
Philip J Saylor, Nancy L Keating, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancer
Philip J Saylor, Richard J Lee, Matthew R Smith
AJR. American Journal of Roentgenology
|
May 25, 2011
Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know
Shahin Tabatabaei, Philip J Saylor, John Coen, et al.
The Oncologist
|
September 19, 2014
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data
Charles J Ryan, Philip J Saylor, Jason J Everly, et al.
European Urology
|
February 23, 2013
Androgen-deprivation therapy and risk for biliary disease in men with prostate cancer
Philip J Saylor, Matthew R Smith, A James O'Malley, et al.
The Journal of Urology
|
April 20, 2010
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer
Philip J Saylor, Donald S Kaufman, M Dror Michaelson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2012
Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer
Philip J Saylor, Umar Mahmood, Anchisa Kunawudhi, et al.
The Journal of Urology
|
June 18, 2011
Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer
Philip J Saylor, Ronald A Morton, Michael L Hancock, et al.
Pituitary
|
April 9, 2021
GnRH agonist-associated pituitary apoplexy: a case series and review of the literature
Francisco J Guarda, Xiaoling Yu, Naila Shiraliyeva, et al.
European Urology
|
December 4, 2012
New and emerging therapies for bone metastases in genitourinary cancers
Philip J Saylor, Andrew J Armstrong, Karim Fizazi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Journal of General Internal Medicine
|
October 20, 2009
Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy
Philip J Saylor, Nancy L Keating, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancer
Philip J Saylor, Richard J Lee, Matthew R Smith
AJR. American Journal of Roentgenology
|
May 25, 2011
Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know
Shahin Tabatabaei, Philip J Saylor, John Coen, et al.
The Oncologist
|
September 19, 2014
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data
Charles J Ryan, Philip J Saylor, Jason J Everly, et al.
European Urology
|
February 23, 2013
Androgen-deprivation therapy and risk for biliary disease in men with prostate cancer
Philip J Saylor, Matthew R Smith, A James O'Malley, et al.
The Journal of Urology
|
April 20, 2010
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer
Philip J Saylor, Donald S Kaufman, M Dror Michaelson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2012
Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer
Philip J Saylor, Umar Mahmood, Anchisa Kunawudhi, et al.
The Journal of Urology
|
June 18, 2011
Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer
Philip J Saylor, Ronald A Morton, Michael L Hancock, et al.
Pituitary
|
April 9, 2021
GnRH agonist-associated pituitary apoplexy: a case series and review of the literature
Francisco J Guarda, Xiaoling Yu, Naila Shiraliyeva, et al.
European Urology
|
December 4, 2012
New and emerging therapies for bone metastases in genitourinary cancers
Philip J Saylor, Andrew J Armstrong, Karim Fizazi, et al.
Page
of 5